Efficacy and Safety of TV-1380 for Facilitation of Abstinence in Cocaine-Dependent Subjects
- Study Title
- Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects
- Teva Identifier
- TV1380-COA-201
- ClinicalTrials.gov Identifier
- NCT01887366
- Study Status
- Completed
- Trial Condition(s)
- Cocaine Addiction
- Interventions
- Drug: TV-1380 150 mg | Drug: TV-1380 300 mg | Drug: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 60 Years
- Trial Duration
- 06/01/2013 - 10/01/2014
- Phase
- Phase 2
